Genelux’s Oncolytic Viral Therapy: Pioneering Cancer Treatment & Market Momentum
Genelux Corporation is pioneering oncolytic viral immunotherapies for solid tumors, promising breakthrough cancer treatment amid volatile biopharma markets.
2 minutes to read